ASCO 2016 | The metastatic breast cancer project: accelerating genomics research
Nikhil Wagle
Press brief by Nikhil Wagle, MD of the Dana-Farber Cancer Institute, Boston, MA, on ‘The metastatic breast cancer project: a national direct-to-patient initiative to accelerate genomics research’ at the 2016 Annual Meeting of the American Society of Clinical Oncology (ASCO), held in Chicago, IL.
Related videos
4:18 IMpower110: atezolizumab vs chemo in PD-L1–selected NSCLC
David Spigel
1:58 Targeted therapy in TNBC
Peter Schmid
4:20 KEYNOTE 522: pembrolizumab as neoadjuvant treatment for early TNBC
Peter Schmid
5:14 Adding alpelisib for HR+/HER2- advanced breast cancer in SOLAR-1: adverse event impacts
Hope Rugo
3:01 BYLieve additional cohort: update on the trial of alpelisib in advanced breast cancer from ESMO
Hope Rugo
